BlackRock Fund Advisors’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

BlackRock Fund Advisors’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$10.6M	Buy	711,194 +93,368	+15%	+$1.31M	﹤0.01%	2533
2016 Q3	$7.76M	Buy	617,826 +43,669	+8%	+$438K	﹤0.01%	2610
2016 Q2	$5.17M	Buy	574,157 +48,964	+9%	+$480K	﹤0.01%	2783
2016 Q1	$5.21M	Sell	525,193 -14,666	-3%	-$150K	﹤0.01%	2725
2015 Q4	$6.21M	Buy	539,859 +12,378	+2%	+$153K	﹤0.01%	2716
2015 Q3	$7.12M	Sell	527,481 -53	-0%	-$718	﹤0.01%	2576
2015 Q2	$7.31M	Buy	527,534 +64,508	+14%	+$872K	﹤0.01%	2685
2015 Q1	$6.52M	Buy	463,026 +105,485	+30%	+$1.44M	﹤0.01%	2691
2014 Q4	$4.87M	Buy	357,541 +50,832	+17%	+$695K	﹤0.01%	2891
2014 Q3	$4.68M	Sell	306,709 -12,779	-4%	-$196K	﹤0.01%	2792
2014 Q2	$5.38M	Buy	319,488 +142,421	+80%	+$2.56M	﹤0.01%	2791
2014 Q1	$3.55M	Buy	177,067 +12,401	+8%	+$268K	﹤0.01%	2999
2013 Q4	$3.19M	Buy	+164,666	New	+$2.91M	﹤0.01%	3042

Other funds holding OXFD

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

BlackRock Fund Advisors's OXFD Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Oxford Immunotec Global PLC Ordinary Shares (OXFD) stake by 15% in Q4 2016, buying an estimated $1.31M and bringing the position to 711,194 shares worth $10.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2533.

BlackRock Fund Advisors first reported a position in OXFD in Q4 2013 and has held it in 13 quarters since. 73 funds tracked by Wall St. Rank hold OXFD as of Q4 2016.

BlackRock Fund Advisors held 711,194 shares of Oxford Immunotec Global PLC Ordinary Shares worth $10.6M as of Q4 2016.
BlackRock Fund Advisors bought 93,368 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2016, an estimated $1.31M.
Oxford Immunotec Global PLC Ordinary Shares made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2533 holding.
BlackRock Fund Advisors first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and has held it in 13 quarters since.
73 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.